1l5s: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="1l5s" size="450" color="white" frame="true" align="right" spinBox="true" caption="1l5s, resolution 2.10Å" /> '''Human liver glycoge... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1l5s.gif|left|200px]]<br /> | [[Image:1l5s.gif|left|200px]]<br /><applet load="1l5s" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="1l5s" size=" | |||
caption="1l5s, resolution 2.10Å" /> | caption="1l5s, resolution 2.10Å" /> | ||
'''Human liver glycogen phosphorylase complexed with uric acid, N-Acetyl-beta-D-glucopyranosylamine, and CP-403,700'''<br /> | '''Human liver glycogen phosphorylase complexed with uric acid, N-Acetyl-beta-D-glucopyranosylamine, and CP-403,700'''<br /> | ||
==Overview== | ==Overview== | ||
Human liver glycogen phosphorylase (HLGP) catalyzes the breakdown of | Human liver glycogen phosphorylase (HLGP) catalyzes the breakdown of glycogen to maintain serum glucose levels and is a therapeutic target for diabetes. HLGP is regulated by multiple interacting allosteric sites, each of which is a potential drug binding site. We used surface plasmon resonance (SPR) to screen for compounds that bind to the purine allosteric inhibitor site. We determined the affinities of a series of compounds and solved the crystal structures of three representative ligands with K(D) values from 17-550 microM. The crystal structures reveal that the affinities are partly determined by ligand-specific water-mediated hydrogen bonds and side chain movements. These effects could not be predicted; both crystallographic and SPR studies were required to understand the important features of binding and together provide a basis for the design of new allosteric inhibitors targeting this site. | ||
==Disease== | ==Disease== | ||
| Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
1L5S is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NBG, PLP, 700, URC and MRD as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Phosphorylase Phosphorylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.1.1 2.4.1.1] Full crystallographic information is available from [http:// | 1L5S is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=NBG:'>NBG</scene>, <scene name='pdbligand=PLP:'>PLP</scene>, <scene name='pdbligand=700:'>700</scene>, <scene name='pdbligand=URC:'>URC</scene> and <scene name='pdbligand=MRD:'>MRD</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Phosphorylase Phosphorylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.1.1 2.4.1.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1L5S OCA]. | ||
==Reference== | ==Reference== | ||
| Line 18: | Line 17: | ||
[[Category: Phosphorylase]] | [[Category: Phosphorylase]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Carty, M | [[Category: Carty, M D.]] | ||
[[Category: Culp, J.]] | [[Category: Culp, J.]] | ||
[[Category: Danley, D | [[Category: Danley, D E.]] | ||
[[Category: Day, Y | [[Category: Day, Y S.N.]] | ||
[[Category: Ekstrom, J | [[Category: Ekstrom, J L.]] | ||
[[Category: Fletterick, R | [[Category: Fletterick, R J.]] | ||
[[Category: Gibbs, E | [[Category: Gibbs, E M.]] | ||
[[Category: Hoover, D | [[Category: Hoover, D J.]] | ||
[[Category: Myszka, D | [[Category: Myszka, D G.]] | ||
[[Category: Pauly, T | [[Category: Pauly, T A.]] | ||
[[Category: Rath, V | [[Category: Rath, V L.]] | ||
[[Category: Soeller, W | [[Category: Soeller, W C.]] | ||
[[Category: Treadway, J | [[Category: Treadway, J L.]] | ||
[[Category: 700]] | [[Category: 700]] | ||
[[Category: MRD]] | [[Category: MRD]] | ||
| Line 39: | Line 38: | ||
[[Category: purine site]] | [[Category: purine site]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:41:37 2008'' | ||